New Migraine Medication Atogepant Offers Prompt Relief – Study found in December 2024
Migraines are not just headaches; they are severe, debilitating experiences that affect millions of people worldwide.
The recent development and approval of a new drug, atogepant, marks a significant advance in the fight against this disabling condition.
A study published on December 23, 2024, in Neurology®, the medical journal of the American Academy of Neurology, highlights its effectiveness and rapid action in preventing migraines, offering new hope to those afflicted.
Key takeaways
- Quick Prevention: Atogepant (QULIPTA®) rapidly reduces migraine frequency from the first day of use.
- Action Mechanism: Functions as a CGRP receptor antagonist to prevent migraine triggers.
- Side Effects & Costs: Includes nausea and drowsiness; costs vary, assistance programs may be available.
Introduction to Atogepant: The Brand Name QULIPTA®
Atogepant is marketed under the brand name QULIPTA®. This prescription medication comes as a significant development in the pharmaceutical landscape, specifically targeting the prevention of migraine attacks before they start.
QULIPTA® stands out because it begins to work quickly, a feature that is highly appreciated by those who need immediate relief from the debilitating effects of migraines.
Rapid Effectiveness of Atogepant
The recent study involving atogepant demonstrated its quick efficacy.
Participants who used atogepant reported experiencing fewer migraines from the first day of the study compared to those who took a placebo.
Over the initial four weeks, there was a consistent reduction in migraine frequency, showcasing atogepant’s potential as a rapid response treatment.
Atogepant’s Mechanism of Action
Atogepant belongs to a class of drugs known as CGRP receptor antagonists.
CGRP, or calcitonin gene-related peptide, is a molecule involved in migraine attacks.
By blocking this receptor, atogepant prevents the peptide from triggering the inflammation and vasodilation associated with migraine headaches.
This mode of action is part of why atogepant can prevent the onset of migraines, altering the approach to migraine management by targeting one of the root causes of the pain.
Consideration of Atogepant Side Effects
Like all strong prescription medications, atogepant comes with potential side effects:
Frequently Observed:
- Constipation
- Nausea
- Sleepiness or unusual drowsiness
- Uncommon fatigue or weakness
Less Frequently Observed:
- Reduced appetite
- Weight loss
Rare Incidences:
- Chest constriction
- Coughing
- Difficulty in swallowing
- Dizziness
- Rapid heartbeat
- Hives, itching, or skin rashes
- Swelling around the eyes, face, lips, or tongue
- Breathing difficulties
Additional Side Effects: Other side effects not previously mentioned may also occur. Should you observe any different effects, it’s important to consult with your healthcare provider.
Pricing and Accessibility of Atogepant
The cost of atogepant, or QULIPTA®, can vary based on location and insurance coverage. However, the manufacturer, AbbVie, might offer patient assistance programs to help mitigate the costs for those who need it most. Patients are encouraged to consult with their healthcare providers and insurance companies to understand the cost implications and available support to access this promising new treatment option.
Conclusion
The introduction of atogepant as QULIPTA® into the market is a welcomed advancement in migraine treatment.
With ongoing research and feedback from the broader patient community, healthcare providers hope to refine migraine management strategies and improve outcomes for patients worldwide.
Sources
- American Academy of Neurology Journal reference: Ramos, A. R., et al. (2024). Sleep Disordered Breathing and Subsequent Neuroimaging Markers of Brain Health in Hispanic/Latino Adults. Neurology. doi.org/10.1212/wnl.0000000000210183.
- https://www.qulipta.com
- https://www.drugs.com/qulipta.html
Most Read
Migraine with Aura: How to reduce daily impact and long-term health risks
Migraines with aura are not just painful—they carry significant health risks, including an increased likelihood of stroke, seizures, blood clots, and heart attacks, especially for women. Aura symptoms, such as visual disturbances, tingling sensations, or speech difficulties, are linked to neurological waves in the brain, triggered by factors like stress, hormonal changes, and nutrient deficiencies.
Alternative Therapies
2 Aug 2024
7 min read
Butterbur for Migraine: Prevention, effectiveness, and safety
Do you suffer from migraines that interfere with daily life? Have you tried every medication and remedy under the sun with no success? While there are numerous pharmacological treatments available for migraine prevention and relief, many individuals seek alternative or complementary therapies to manage migraine symptoms. Butterbur is one of the most-studied and most-effective natural […]
Natural Remedies
2 Aug 2024
5 min read
Can weather cause migraine headaches? A forecast for fewer headache days
For centuries, individuals afflicted with migraines have reported a curious phenomenon: their headaches seem to wax and wane with changes in the weather. From the onset of a storm, to shifts in temperature, humidity or barometric pressure, the connection between migraine and weather has long captured the attention of scientists and sufferers alike. In this […]
Alternative Therapies
2 Aug 2024
8 min read
Managing Migraines at Work: Strategies and Considerations
Migraines are debilitating neurological conditions that can significantly impact an individual’s ability to function, both at home and in the workplace. Managing migraine symptoms while trying to maintain a career can be challenging. In this article, we will explore your rights and responsibilities in the workplace, plus practical strategies for managing migraines at work and […]